News


A New Drug Shines Hope On Lung Cancer

The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumours that …



Quitting smoking with ease after a stroke

A new research published in the Journal of Addictive Behaviors suggested an association between brain stroke and smoke cessation. The researchers found that smokers who suffered a brain stroke in a specific region (the insular …



Nestle Takes On The Fight For Alzheimer’s

Food group Nestle has taken a further step into the medication business by signing a Swiss biotech company on a research cooperation agreement to come up with an Alzheimer’s disease diagnostic test. The second medical …



FDAs New Approved Digital Pill

Individuals suffering from chronic illnesses are supposed to take their medicine consistently, but when a patients forgets to do that, or days are skipped between prescription refills, the results can be severe enough to require …


EU first approved NOAC Xarelto

EU approved the very first NOAC (or novel oral anticoagulant) Xarelto (rivaroxaban) for broad application. With Bayer and Janssen at the helm, Xarelto can now be broadly used for patients suffering from atrial fibrillation (AF). …


Vaccines and Autism: Italy Raises Concern

There’s a rising concern about the potential association between vaccination and autism. Although this correlation has never been confirmed by sufficient clinical evidence, it is a fact that vaccines are neither completely safe nor completely …